Regenerative Medical Technology Group Inc.
RMTG
$0.0531
$0.00316.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.82% | -19.08% | 28.06% | 57.28% | -5.89% |
| Total Depreciation and Amortization | 5.79% | 286.33% | -131.31% | 6.99% | 8.36% |
| Total Amortization of Deferred Charges | -- | -- | -93.34% | -93.59% | 0.64% |
| Total Other Non-Cash Items | -41.67% | 233.33% | -175.00% | 71.43% | -53.33% |
| Change in Net Operating Assets | -22.23% | -26.65% | 3.77% | -4.55% | 8.88% |
| Cash from Operations | -1,147.46% | -84.95% | 39.03% | 201.88% | -16.30% |
| Capital Expenditure | -- | -- | 6.72% | -1.71% | 10.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 6.72% | -1.71% | 10.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 585.29% | -82.67% | 50.21% | 481.70% | -22.75% |